A recent review of studies has revealed significant differences in the cardiometabolic side effects of several antidepressants. These findings suggest that existing clinical guidelines need updating to reflect the various implications these medications may have for patients' cardiometabolic risk. The research highlights the need for careful evaluation when prescribing antidepressants, due to the different safety profiles each one presents with respect to the heart and the patients' metabolism.
Experts suggest that, although guidelines should be revised to integrate these new data, the selection of the appropriate antidepressant should remain an individualized process, tailored to the needs and specific characteristics of each patient. Personalization of treatment is key to minimizing the associated risks and maximizing the effectiveness of the medication, considering the patient's overall health and possible side effects.
Read the full news article on The World.
